vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是FLEXIBLE SOLUTIONS INTERNATIONAL INC的1.5倍（$13.7M vs $9.1M），FLEXIBLE SOLUTIONS INTERNATIONAL INC净利率更高（-5.1% vs -10.3%，领先5.3%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -0.5%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-4.0M），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs -0.6%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
CPIX vs FSI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $9.1M |
| 净利润 | $-1.4M | $-460.9K |
| 毛利率 | 83.6% | 29.4% |
| 营业利润率 | -10.0% | 11.6% |
| 净利率 | -10.3% | -5.1% |
| 营收同比 | 31.1% | -0.5% |
| 净利润同比 | 25.8% | -167.8% |
| 每股收益（稀释后） | $-0.09 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.7M | $9.1M | ||
| Q3 25 | $8.3M | $10.6M | ||
| Q2 25 | $10.8M | $11.4M | ||
| Q1 25 | $11.7M | $7.5M | ||
| Q4 24 | $10.4M | $9.2M | ||
| Q3 24 | $9.1M | $9.3M | ||
| Q2 24 | $9.8M | $10.5M | ||
| Q1 24 | $8.5M | $9.2M |
| Q4 25 | $-1.4M | $-460.9K | ||
| Q3 25 | $-1.9M | $-503.4K | ||
| Q2 25 | $-740.7K | $2.0M | ||
| Q1 25 | $1.3M | $-277.7K | ||
| Q4 24 | $-1.9M | $679.6K | ||
| Q3 24 | $-1.5M | $611.9K | ||
| Q2 24 | $-1.1M | $1.3M | ||
| Q1 24 | $-1.9M | $457.2K |
| Q4 25 | 83.6% | 29.4% | ||
| Q3 25 | 88.1% | 23.9% | ||
| Q2 25 | 81.4% | 47.4% | ||
| Q1 25 | 87.8% | 26.1% | ||
| Q4 24 | 81.1% | 29.2% | ||
| Q3 24 | 85.4% | 40.9% | ||
| Q2 24 | 82.6% | 37.4% | ||
| Q1 24 | 81.5% | 30.6% |
| Q4 25 | -10.0% | 11.6% | ||
| Q3 25 | -23.7% | 2.9% | ||
| Q2 25 | -6.9% | 29.0% | ||
| Q1 25 | 11.0% | -0.9% | ||
| Q4 24 | -17.7% | 9.4% | ||
| Q3 24 | -18.6% | 20.5% | ||
| Q2 24 | -10.4% | 18.7% | ||
| Q1 24 | -22.0% | 8.3% |
| Q4 25 | -10.3% | -5.1% | ||
| Q3 25 | -23.4% | -4.8% | ||
| Q2 25 | -6.8% | 17.8% | ||
| Q1 25 | 10.7% | -3.7% | ||
| Q4 24 | -18.2% | 7.4% | ||
| Q3 24 | -17.0% | 6.6% | ||
| Q2 24 | -11.0% | 12.3% | ||
| Q1 24 | -22.9% | 5.0% |
| Q4 25 | $-0.09 | $-0.03 | ||
| Q3 25 | $-0.13 | $-0.04 | ||
| Q2 25 | $-0.05 | $0.15 | ||
| Q1 25 | $0.08 | $-0.02 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | $-0.11 | $0.05 | ||
| Q2 24 | $-0.08 | $0.10 | ||
| Q1 24 | $-0.14 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | — |
| 总债务越低越好 | — | $4.4M |
| 股东权益账面价值 | $24.9M | $38.9M |
| 总资产 | $76.8M | $61.8M |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
| Q4 25 | $11.4M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $16.1M | $10.0M | ||
| Q1 25 | $15.1M | $11.0M | ||
| Q4 24 | $18.0M | $10.0M | ||
| Q3 24 | $17.5M | $13.0M | ||
| Q2 24 | $17.3M | $9.2M | ||
| Q1 24 | $18.5M | $8.3M |
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $24.9M | $38.9M | ||
| Q3 25 | $26.1M | $39.0M | ||
| Q2 25 | $28.0M | $39.4M | ||
| Q1 25 | $28.7M | $38.4M | ||
| Q4 24 | $22.9M | $38.0M | ||
| Q3 24 | $24.8M | $36.9M | ||
| Q2 24 | $26.3M | $36.2M | ||
| Q1 24 | $27.5M | $36.0M |
| Q4 25 | $76.8M | $61.8M | ||
| Q3 25 | $65.9M | $58.4M | ||
| Q2 25 | $67.9M | $58.2M | ||
| Q1 25 | $69.9M | $61.7M | ||
| Q4 24 | $75.6M | $60.0M | ||
| Q3 24 | $76.7M | $57.8M | ||
| Q2 24 | $78.5M | $56.3M | ||
| Q1 24 | $81.5M | $57.6M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-4.0M |
| 自由现金流率自由现金流/营收 | 0.0% | -44.3% |
| 资本支出强度资本支出/营收 | 0.0% | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $-591.7K |
8季度趋势，按日历期对齐
| Q4 25 | $3.0K | $-3.0M | ||
| Q3 25 | $187.2K | $2.0M | ||
| Q2 25 | $843.8K | $5.3M | ||
| Q1 25 | $3.9M | $-544.3K | ||
| Q4 24 | $1.9M | $-2.2M | ||
| Q3 24 | $475.5K | $2.5M | ||
| Q2 24 | $-855.7K | $5.9M | ||
| Q1 24 | $-2.1M | $-604.8K |
| Q4 25 | $3.0K | $-4.0M | ||
| Q3 25 | $163.4K | $39.4K | ||
| Q2 25 | $817.3K | $4.3M | ||
| Q1 25 | $3.9M | $-898.4K | ||
| Q4 24 | $1.9M | $-4.3M | ||
| Q3 24 | $460.1K | $1.3M | ||
| Q2 24 | $-862.8K | $4.7M | ||
| Q1 24 | $-2.2M | $-1.1M |
| Q4 25 | 0.0% | -44.3% | ||
| Q3 25 | 2.0% | 0.4% | ||
| Q2 25 | 7.5% | 37.9% | ||
| Q1 25 | 32.9% | -12.0% | ||
| Q4 24 | 18.2% | -47.0% | ||
| Q3 24 | 5.1% | 13.6% | ||
| Q2 24 | -8.8% | 44.9% | ||
| Q1 24 | -25.6% | -11.7% |
| Q4 25 | 0.0% | 11.7% | ||
| Q3 25 | 0.3% | 18.7% | ||
| Q2 25 | 0.2% | 8.6% | ||
| Q1 25 | 0.4% | 4.7% | ||
| Q4 24 | 0.0% | 22.8% | ||
| Q3 24 | 0.2% | 13.0% | ||
| Q2 24 | 0.1% | 11.3% | ||
| Q1 24 | 0.5% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | — | 4.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
